Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Osteoporos Int. 2020 Apr 1;31(8):1499–1506. doi: 10.1007/s00198-020-05372-6

Table 3. Other sensitivity analyses.

Scenario QALY difference per patient, screening vs. usual management
Base case 0.015
5% discount rates 0.014
0% discount rates 0.020
10-year modelling time horizon 0.012
100% of excess mortality attributable to fractures 0.019